Table 3.

Summarized results of the simulations. Costs, strokes, and fatal strokes classified on the basis of the CHA₂DS₂-VASc score as well as the investigated group (N=30,000 patients per group per score).

	Study arm without device				Study arm with device (50% ECGa confirmation)
CHA2DS2-VASc scoreb	Average costs per patient (in €c, whole simulation duration)	Total number of strokesd	Number of nonfatal strokes	Number of fatal strokes	Average costs per patient (in €, whole simulation duration)	Total number of strokesd	Number of nonfatal strokes	Number of fatal strokes
1	873	581	379	202	1330	599	402	197
2	2280	2338	1571	767	2788	2351	1513	838
3	3351	3493	2283	1210	3815	3460	2232	1228
4	4860	5260	3288	1972	5239	4903	3100	1803
5	6877	7808	4844	2964	7233	7437	4569	2858
6	8802	10,397	6286	4111	9375	10,163	6228	3935
7	10,023	11,804	7024	4780	10,414	11,237	6857	4380
8	10,154	11,485	6591	4894	10,761	11,039	6469	4570
9	11,299	12,565	6944	5621	12,086	12,201	6964	5237
mean	6502	7303	4357	2947	7005	7043	4259	2784

^aECG: electrocardiography.

^bCHA₂DS₂-VASc: Congestive heart failure, Hypertension, Age≥75 years, Diabetes mellitus, Stroke, Vascular disease, Age 65-74 years, Sex category (female).

^c€1=US $1.12.

^dTotal number of strokes includes nonfatal and fatal strokes.